Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63187-943

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 63187-943). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-943-30 (Valsahctz 80 125mg)

63187-943-30 (Valsahctz 80 125mg)
This is a description of a prescription medication called Valsartan HCTZ 80mg/12.5mg, produced by Alembic Pharmaceuticals Limited and packaged by Proficient Rx LP. Each package contains 30 light orange, oval-shaped, film-coated tablets, each of which contains 80mg of Valsartan USP and 12.5mg of Hydrochlorothiazide USP. The tablets are marked with 'L235' on one side and are plain on the other side, with an NDC number of 63187-943-30. The lot number is 00000, with an expiry date of 00/00/00. The medication is for prescription use only, and must be stored at 25°C (77°F) and kept out of the reach of children.*
FDA Label Image

Figure 1 (Valsahctz Figur1)

Figure 1 (Valsahctz Figur1)
This is a chart displaying the probability of achieving systolic blood pressure levels lower than 140 mmHg after 8 weeks using a combination of Valsartan and Hydrochlorothiazide tablets. The chart shows blood pressure levels ranging from 140 to 180 mmHg at baseline. The text also includes medication dosages, but no additional useful description can be derived from them alone.*
FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

Figure 2-3-4 (Valsahctz Figure2 3 4)
This is a medical report showing graphs depicting the probability of achieving specific blood pressure readings during the 8th week while taking Valsartan and Hydrochlorothiazide tablets at different dosages. The graphs show the probability of achieving systolic and diastolic blood pressure levels of less than 130 mmHg, less than 90 mmHg, and less than 80 mmHg respectively.*
FDA Label Image

Structure (Valsahctz Hctz)

FDA Label Image

Structure (Valsahctz Valsa)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.